التداخل بين إيزيتيميب وسيمفاستاتين ولوفاستاتين

However, another HMG-CoA reductase inhibitor has been found to produce a less than two-second increase in prothrombin time in healthy volunteers receiving low doses of warfarin.

Another HMG-CoA reductase inhibitor has been shown to reduce the plasma testosterone response to HCG.

The risk is also greater in patients taking VYTORIN 80 mg daily compared with patients taking lower VYTORIN dosages and compared with patients using other statins with similar or greater LDL-C-lowering efficacy [see Adverse Reactions (6.1) ] .